Skip to main content
SpringerLink
Log in

Epidemiology

  • Chapter
Hidradenitis Suppurativa

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fitzsimmons JS, Fitzsimmons EM, Gilbert G (1984) Familial hidradenitis suppurativa: evidence in favor of a single gene transmission. J Med Genet 21:281–285.

    Article  PubMed  CAS  Google Scholar 

  2. Fitzsimmons JS, Guilbert PR, Fitzsimmons EM (1985) Evidence of genetic factors in hidradenitis suppurativa. Br J Dermatol 113: 1–8.

    Article  PubMed  CAS  Google Scholar 

  3. Lookingbill DP (1988) Yield from a complete skin examination. Findings in 1157 new dermatology patients. J Am Acad Dermatol 18: 31–37.

    Article  PubMed  CAS  Google Scholar 

  4. Jemec GB (1988) The symptomatology of hidradenitis suppurativa in women. Br J Dermatol 119:345–350.

    Article  PubMed  CAS  Google Scholar 

  5. Harrison BJ, Mudge M, Hughes LE (1991) The prevalence of hidradenitis suppurativa in South Wales. In: Marks R, Plewig G (eds) Acne and related disorders. Martin Dunitz, London, pp 365–366.

    Google Scholar 

  6. Jemec GB, Heidenheim M, Nielsen NH (1996) The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 35(2 Pt 1): 191–194.

    Article  PubMed  CAS  Google Scholar 

  7. Mahe A, Cisse IA, Faye O, N’Diaye HT, Niamba P (1998) Skin diseases in Bamako (Mali). Int J Dermatol 37: 673–676.

    Article  PubMed  CAS  Google Scholar 

  8. TNS Sofres survey (2005) Enquête. Les français et la dermatologie. Unpublished document

    Google Scholar 

  9. Von der Werth JM, Williams HC, Raeburn JA (2000) The clinical genetics of hidradenitis suppurativa revisited. Br J Dermatol 142: 947–953.

    Article  Google Scholar 

  10. Knaysi GA, Cosman B, Crikelair GF (1968) Hidradenitis suppurativa. J Am Med Assoc 203: 19–22.

    Article  Google Scholar 

  11. Konig A, Lehmann C, Rompel R, Happle R (1999) Cigarette smoking as a triggering factor of hidradenitis suppurativa. Dermatology 198: 261–264.

    Article  PubMed  CAS  Google Scholar 

  12. Barth JH, Layton AM, Cunliffe WJ (1997) Endocrine factors in pre-and postmenopausal women with hidradenitis suppurativa. Br J Dermatol 136:802–803.

    Google Scholar 

  13. Morgan WP, Leicester G (1982) The role of depilation and deodorants in hidradenitis suppurativa. Arch Dermatol 118: 101–102.

    Article  PubMed  CAS  Google Scholar 

  14. Jemec GB, Heidenheim M, Nielsen NH (1996) Hidradenitis suppurativa — characteristics and consequences. Clin Exp Dermatol 21: 419–423.

    Article  PubMed  CAS  Google Scholar 

  15. Jemec GB, Heidenheim M, Nielsen NH (1996) A case-control study of hidradenitis suppurativa in an STD population. Acta Derm Venereol 76: 482–483.

    PubMed  CAS  Google Scholar 

  16. Lapins J, Ye W, Nyren O, Emtestam L (2001) Incidence of cancer among patients with hidradenitis suppurativa. Arch Dermatol 137: 730–734.

    PubMed  CAS  Google Scholar 

  17. Martinez F, Nos P, Benlloch S, Ponce J (2001) Hidradenitis suppurativa and Crohn’s disease: response to treatment with infliximab. Inflamm Bowel Dis 7: 323–326.

    Article  PubMed  CAS  Google Scholar 

  18. Katsanos KH, Christodoulou DK, Tsianos EV (2002) Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn’s disease patient. Am J Gastroenterol 97: 2155–2156.

    Article  PubMed  Google Scholar 

  19. Birrenbach T, Bocker U (2004) Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. In-flamm Bowel Dis10: 848–859.

    Article  Google Scholar 

  20. Hurley HJ (1996) Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and familial benign pemphigus. Surgical approach. In: Roenigk RK, Roenigk HH Jr (eds) Dermatologic surgery. Principles and practice, 2nd edn. Marcel Dekker, New York, pp 623–645.

    Google Scholar 

  21. Sartorius K, Lapins J, Emtestam L, Jemec GB (2003) Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol 149: 211–213.

    Article  PubMed  CAS  Google Scholar 

  22. Hospital discharge data. Taken from the Healthcare Cost and Utilization Project (HCUP), April 2, 2005.

    Google Scholar 

  23. Jemec GBE, Wendelboe P (1998) Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol 39(6): 971.

    Article  PubMed  CAS  Google Scholar 

  24. von der Werth JM, Jemec GB (2001) Morbidity in patients with hidradenitis suppurativa. Br J Dermatol 144: 809–813.

    Article  PubMed  Google Scholar 

  25. von der Werth JM, Williams HC (2000) The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 14: 389–392.

    Article  PubMed  Google Scholar 

  26. Jemec G (2003) Hidradenitis suppurativa. J Cutan Med Surg 7(1): 47–56.

    Article  PubMed  Google Scholar 

  27. Rosner IA, Burg CG, Wisnieski JJ, Schacter BZ, Richter DE (1993) The clinical spectrum of the arthropathy associated with hidradenitis suppurativa and acne conglobata. J Rheumatol 20:684–687.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. U.O. Dermatologia Ospedali Riuniti, Centro Studi GISED, L.go Barozzi 1, 24128, Bergamo, Italy

    Luigi Naldi

Authors
  1. Luigi Naldi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Roskilde Hospital, Department of Dermatology, University of Copenhagen, Køgevej 7-13, 4000, Roskilde, Denmark

    Gregor B. E. Jemec MD, DMedSc

  2. Service Dermatologie, CHU Henri Mondor, Avenue Marechal de Lattre de Tassigny 51, 94010, Créteil, CX, France

    Jean Revuz MD, DMedSc

  3. Department of Dermatology, University Hospital of Pennsylvania, Spruce Street 3400, 19104, Philadelphia, USA

    James J. Leyden MD

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Naldi, L. (2006). Epidemiology. In: Jemec, G.B.E., Revuz, J., Leyden, J.J. (eds) Hidradenitis Suppurativa. Springer, Berlin, Heidelberg . https://doi.org/10.1007/978-3-540-33101-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-33101-8_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-33100-1

  • Online ISBN: 978-3-540-33101-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation